MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
0.6508
-0.0033
-0.50%
Opening 10:29 03/30 EDT
OPEN
0.6700
PREV CLOSE
0.6541
HIGH
0.6817
LOW
0.6202
VOLUME
86.10K
TURNOVER
--
52 WEEK HIGH
19.30
52 WEEK LOW
0.6202
MARKET CAP
545.88K
P/E (TTM)
-0.0009
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BDRX last week (0323-0327)?
Weekly Report · 8h ago
Biodexa Pharmaceuticals Posts 2025 Preliminary Results and Deepens GI Cancer-Focused Pipeline
TipRanks · 2d ago
Preliminary Results for the Year Ended 31 December 2025
Barchart · 3d ago
Biodexa Pharmaceuticals management to meet with Maxim
TipRanks · 03/23 14:45
Biodexa Pharma Enters Into Strategic Partnership With Tanner Pharma Group To Make eRapa Available For FAP Patients Via Early Access Program And Named Patient Prescribing
Benzinga · 03/23 12:33
Weekly Report: what happened at BDRX last week (0316-0320)?
Weekly Report · 03/23 10:01
Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
TipRanks · 03/18 22:00
Biodexa Pharmaceuticals announces ADR ratio change
Seeking Alpha · 03/18 21:10
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.